Health Cluster Portugal: from knowledge to market

You are here:

Homepage Membership Directory Ipatimup - Instituto de Patologia e Imunologia Molecular da Universidade do Porto

Last update

14-04-2015

Ipatimup - Instituto de Patologia e Imunologia Molecular da Universidade do Porto

http://www.ipatimup.pt/

Category(ies): Contract Research Organisations; Healthcare Providers; Public / Nonprofit Organisations

Subcluster(s):

Address: Rua Dr. Roberto Frias, s/n; 4200-465 Porto; Portugal

Related links:

Keyword(s): Cancer, Cancer Diagnosis, Cancer Genetics, Health Sciences, Research & Development

The Institute of Molecular Pathology and Immunology of the University of Porto is a private non-profit association of public utility. Ipatimup performs basic and translational research and provides advanced training in oncobiology and pathology. Long term goals of Ipatimup are: 1. to keep a world-competitive research level on thyroid and gastric cancer and to achieve international prominence in research of other epithelial derived cancers (colorectal, breast and pancreas) and in other tumours; 2. to contribute, through the results of its basic and translational research, as well as through partnerships with other institutions (hospitals, research centers, pharmaceutical industry and biotechs) to the improvement of prevention and early diagnosis of cancer and for the targeted treatment of patients. Ipatimup, in collaboration with IPO/Porto, is accredited as a Comprehensive Cancer Center of the European Organization of Cancer Institutes. Ipatimup is interested in developing new technologic research tools to address the molecular mechanisms and clinical problems related to cancer. Ipatimup is a reference center for the detection of KRAS mutations in colorectal cancer, EGFR mutations in lung cancer, HER2 testing in breast and gastric cancer, among other tests. It is also a reference lab for the genetic diagnosis of hereditary cancer syndromes. Ipatimup performs 20.000 cancer diagnosis per year and ensures 300-400 consultation cancer cases to international institutions.

R&D Projects

Announcements/Opportunities